5-carboxamidotryptamine and 3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide

5-carboxamidotryptamine has been researched along with 3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bax, WA; Maassen VanDenBrink, A; Reekers, M; Saxena, PR1

Other Studies

1 other study(ies) available for 5-carboxamidotryptamine and 3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide

ArticleYear
Human isolated coronary artery contraction to sumatriptan characterised by the selective 5-HT1B/1D receptor antagonist GR55562.
    Pharmacology & toxicology, 2000, Volume: 86, Issue:6

    Topics: Benzamides; Coronary Vessels; Dinoprost; Dose-Response Relationship, Drug; Drug Interactions; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Potassium; Pyridines; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Substance P; Sumatriptan; Vasoconstrictor Agents

2000
chemdatabank.com